21 May 2018

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

21 May 2018 | n=57

  1. Molsberry SA, Cheng Y, Kingsley L, Jacobson L, et al.
    Neuropsychological phenotypes among men with and without HIV disease in the multicenter AIDS cohort study.
    AIDS 2018.

  2. Kilburn K, Ranganathan M, Stoner MCD, Hughes JP, et al.
    Transactional sex and incident HIV infection in a cohort of young women from rural South Africa enrolled in HPTN 068.
    AIDS 2018.

  3. Heffron R, Mugo N, Hong T, Celum C, et al.
    Pregnancy outcomes and infant growth among babies with in utero exposure to tenofovir-based pre-exposure prophylaxis for HIV prevention.
    AIDS 2018.

  4. Montgomery ET, Stadler J, Naidoo S, Katz A, et al.
    Reasons for non-adherence to the dapivirine vaginal ring: results of the MTN-032/ AHA study.
    AIDS 2018.

  5. Kong D, Wang Y, Ji P, Li W, et al.
    A defucosylated bispecific multivalent molecule exhibits broad HIV-1 neutralizing activity and enhanced ADCC against reactivated HIV-1 latently infected cells.
    AIDS 2018.

  6. Harris TG, Rabkin M, El-Sadr WM.
    Achieving the 4th 90 - Healthy Aging for People Living with HIV.
    AIDS 2018.

  7. Woodson E, Goldberg A, Michelo C, Basu D, et al.
    HIV transmission in Discordant Couples in Africa in the context of ART availability.
    AIDS 2018.

  8. Dillon SM, Guo K, Austin GL, Gianella S, et al.
    A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis.
    AIDS 2018.

  9. Hoornenborg E, Coyer L, van Laarhoven A, Achterbergh R, et al.
    Change in sexual risk behaviour after six months of pre-exposure prophylaxis use: results from the Amsterdam PrEP demonstration project.
    AIDS 2018.

  10. Duffau P, Ozanne A, Bonnet F, Lazaro E, et al.
    Multimorbidity, age-related comorbidities and mortality: association of activation, senescence and inflammation markers in HIV adults.
    AIDS 2018.

  11. Aluisio AR, Palaniappan A, Farquhar C, Mello MJ, et al.
    Integrated HIV-injury programming: An underutilized intersection to engage young adults in HIV care in low- and middle-income countries.
    AIDS 2018.

  12. Moyo S, Gaseitsiwe S, Powis KM, Pretorius Holme M, et al.
    Undisclosed antiretroviral drug use in Botswana: implication for national estimates.
    AIDS 2018.

  13. Yang J, Sharma A, Shi Q, Anastos K, et al.
    Improved fracture prediction using different FRAX adjustments in HIV-infected women.
    AIDS 2018.

  14. Barnes A, Betts AC, Borton EK, Sanders JM, et al.
    Cervical cancer screening among HIV infected women in an urban, U.S. safety-net healthcare system.
    AIDS 2018.

  15. Tsukamoto T.
    Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34+ cells in HIV-1 infection.
    AIDS 2018.

  16. Winckelmann A, Morcilla V, Shao W, Schleimann MH, et al.
    Genetic characterization of the HIV-1 reservoir after Vacc-4x and romidepsin therapy in HIV-1 infected individuals.
    AIDS 2018.

  17. Gong S, Tomusange K, Kulkarni V, Adeniji OS, et al.
    Anti-HIV IgM protects against mucosal SHIV transmission.
    AIDS 2018.

  18. Cichowitz C, Watt MH, Mmbaga BT.
    Childbirth experiences of women living with HIV: a neglected event in the prevention of mother-to-child transmission care continuum.
    AIDS 2018.

  19. Michal JL, Rab S, Patel M, Kyle A, et al.
    Incidence of acute kidney injury in patients co-infected with HIV and hepatitis C virus receiving tenofovir disoproxil fumarate and ledipasvir/sofosbuvir in a real-world, urban, Ryan White clinic.
    AIDS Res Hum Retroviruses 2018.

  20. Stekler J, Tapia K, Maenza J, Stevens CE, et al.
    No time to delay! Fiebig stages and referral in acute HIV infection: Seattle Primary Infection Program Experience.
    AIDS Res Hum Retroviruses 2018.

  21. Dukhovlinova E, Masharsky A, Vasileva A, Porrello A, et al.
    Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use.
    AIDS Res Hum Retroviruses 2018.

  22. Hiransuthikul A, Wongkanya R, Sirivichayakul S, Trachunthong D, et al.
    Discordance in drug-resistance mutations between blood plasma and semen or rectal secretion among newly diagnosed HIV-1-infected Thai MSM.
    AIDS Res Hum Retroviruses 2018.

  23. Zhao Y, Wu Z, McGoogan JM, Sha Y, et al.
    Nationwide cohort study of antiretroviral therapy timing: treatment dropout and virological failure in China, 2011-2015.
    Clin Infect Dis 2018.

  24. Elliot ER, Wang X, Singh S, Simmons B, et al.
    Increased dolutegravir peak concentrations in people living with HIV aged 60 and over and analysis of sleep quality and cognition.
    Clin Infect Dis 2018.

  25. Lambert-Niclot S, Grude M, Meynard JL, Marcelin AG, et al.
    Ultrasensitive HIV-1 Viral Load as a Marker of Treatment Choice for Simplification Strategies.
    Clin Infect Dis 2018.

  26. Balan IC, Frasca T, Dolezal C, Carballo-Dieguez A, et al.
    HIV Risk Reduction by Avoiding Sex with Partners Unwilling to Undergo HIV Testing is Not Coercion.
    J Acquir Immune Defic Syndr 2018.

  27. Merlin JS, Long D, Becker WC, Cachay ER, et al.
    The Association of Chronic Pain and Long-Term Opioid Therapy with HIV Treatment Outcomes.
    J Acquir Immune Defic Syndr 2018.

  28. Lightfoot MA, Campbell CK, Moss N, Treves-Kagan S, et al.
    Using a Social Network Strategy to Distribute HIV Self-Test Kits to African American and Latino MSM.
    J Acquir Immune Defic Syndr 2018.

  29. Guiteau Moise C, Rivera VR, Hennessey KA, Bellot C, et al.
    A Successful Model of Expedited Antiretroviral Therapy for Clinically Stable Patients Living with HIV in Haiti.
    J Acquir Immune Defic Syndr 2018.

  30. Cahn P, Sax PE, Squires K, Molina JM, et al.
    Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, non-inferiority trial.
    J Acquir Immune Defic Syndr 2018.

  31. Achhra AC, Sabin C, Ryom L, Hatleberg C, et al.
    Body Mass Index and The Risk of Serious Non-Aids Events and All Cause Mortality in Treated Hiv-Positive Individuals: D: A: D Cohort Analysis.
    J Acquir Immune Defic Syndr 2018.

  32. Wake RM, Jarvis JN, Harrison TS, Govender NP, et al.
    Point of Care Cryptococcal Antigen Screening: Pipetting Finger-Prick Blood Improves Performance of Immuno-Mycologics Lateral Flow Assay.
    J Acquir Immune Defic Syndr 2018.

  33. Lopez-Varela E, Fuente-Soro L, Augusto OJ, Sacoor C, et al.
    The Continuum of HIV Care in Rural Mozambique: The Implications of HIV Testing Modality on Linkage and Retention.
    J Acquir Immune Defic Syndr 2018.

  34. Yanik EL, Hernandez-Ramirez RU, Qin L, Lin H, et al.
    Cutaneous Melanoma Risk among People with HIV in the United States and Canada.
    J Acquir Immune Defic Syndr 2018.

  35. Sherman KE, Rouster SD, Kong LX, Shata TM, et al.
    Zika Virus Exposure in an HIV-Infected Cohort in Ghana.
    J Acquir Immune Defic Syndr 2018.

  36. von Braun A, Sekaggya-Wiltshire C, Bachmann N, Ssemwanga D, et al.
    HIV-1 drug resistance among Ugandan adults attending an urban out-patient clinic.
    J Acquir Immune Defic Syndr 2018.

  37. Dyer TV, Khan MR, Regan R, Harawa NT, et al.
    Differential Patterns of Risk and Vulnerability Suggest the Need for Novel Prevention Strategies for Black Bisexual Men in the HPTN 061 Study.
    J Acquir Immune Defic Syndr 2018.

  38. Novitsky V, Gaolathe T, Mmalane M, Moyo S, et al.
    Lack of Virological Suppression among Young HIV-Positive Adults in Botswana.
    J Acquir Immune Defic Syndr 2018.

  39. Shiau S, Strehlau R, Shen J, Violari A, et al.
    Biomarkers of aging in HIV-infected children on suppressive antiretroviral therapy.
    J Acquir Immune Defic Syndr 2018.

  40. Golovaty I, Sharma M, Van Heerden A, van Rooyen H, et al.
    Cost of integrating non-communicable disease screening into home-based HIV testing and counseling in South Africa.
    J Acquir Immune Defic Syndr 2018.

  41. Thirumurthy H, Masters SH, Agot K.
    Willingness to Pay for HIV Self-Tests Among Women in Kenya: Implications for Subsidy and Pricing Policies.
    J Acquir Immune Defic Syndr 2018;78:e8-e11.

  42. Ranzani A, Oreni L, Agro M, van den Bogaart L, et al.
    Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    J Acquir Immune Defic Syndr 2018;78:193-201.

  43. Justman JE, Nair GL, Hendrix CW, Piper JM, et al.
    Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
    J Acquir Immune Defic Syndr 2018;78:175-182.

  44. Jotwani V, Scherzer R, Glidden DV, Mehrotra M, et al.
    Pre-exposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine and Kidney Tubular Dysfunction in HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr 2018;78:169-174.

  45. Maughan-Brown B, George G, Beckett S, Evans M, et al.
    HIV Risk Among Adolescent Girls and Young Women in Age-Disparate Partnerships: Evidence From KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr 2018;78:155-162.

  46. .
    Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome: Erratum.
    J Acquir Immune Defic Syndr 2018;78:e13.

  47. Radtke KK, Bacchetti P, Anastos K, Merenstein D, et al.
    Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.
    J Acquir Immune Defic Syndr 2018;78:202-208.

  48. Burger EA, Dyer MA, Sy S, Palefsky JM, et al.
    Development and Calibration of a Mathematical Model of Anal Carcinogenesis for High-Risk HIV-Infected Men.
    J Acquir Immune Defic Syndr 2018.

  49. Twisk DE, van der Sande MAB, van Eeden A, Heideman DAM, et al.
    Detection of Incident Anal High-Risk Hpv-Dna in Msm: Incidence or Reactivation?
    J Infect Dis 2018.

  50. Reichler MR, Khan A, Sterling TR, Zhao H, et al.
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis 2018.

  51. Koay WLA, Lindsey JC, Uprety P, Bwakura-Dangarembizi M, et al.
    Intestinal Integrity Biomarkers in Early Antiretroviral-Treated Perinatally HIV-1-Infected Infants.
    J Infect Dis 2018.

  52. Carey BD, Ammosova T, Pinkham C, Lin X, et al.
    Protein Phosphatase 1alpha Interacts with Venezuelan Equine Encephalitis Virus Capsid Protein and Regulates Viral Replication through Modulation of Capsid Phosphorylation.
    J Virol 2018.

  53. Kumar S, Morrison JH, Dingli D, Poeschla E, et al.
    HIV-1 activation of innate immunity depends strongly on the intracellular level of TREX1 and sensing of incomplete reverse transcription products.
    J Virol 2018.

  54. Justman JE, Mugurungi O, El-Sadr WM.
    HIV Population Surveys - Bringing Precision to the Global Response.
    N Engl J Med 2018;378:1859-1861.

  55. Zuger A.
    Moving On.
    N Engl J Med 2018;378:1763-1765.

  56. Gomez CA, Banaei N.
    Trypanosoma cruzi Reactivation in the Brain.
    N Engl J Med 2018;378:1824.

  57. Huibers MHW, Moons P, Maseko N, Gushu MB, et al.
    Multiplex Real-Time PCR Detection of Intestinal Protozoa in HIV-Infected Children in Malawi, Enterocytozoon Bieneusi is Common and Associated with Gastrointestinal Complaints and May Delay BMI (Nutritional Status) Recovery.
    Pediatr Infect Dis J 2018.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

21 May 2018

14 May 2018

07 May 2018

30 April 2018

23 April 2018


21 May 2018

Multidisciplinary Journal Club

  1. Zhang M, Wang C, Otto TD, Oberstaller J, et al.
    Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis.
    Science. 2018;360.

  2. Pang Y, Kartsonaki C, Turnbull I, Guo Y, et al.
    Diabetes, plasma glucose and incidence of fatty liver, cirrhosis and liver cancer: A prospective study of 0.5 million people.
    Hepatology. 2018 May 7. doi: 10.1002/hep.30083.

  3. Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, et al.
    Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries
    J Clin Oncol. 2018 May 10:JCO2017759308. doi: 10.1200/JCO.2017.75.9308.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016